Live vaccine for the vaccination of chickens against very virulent Marek Disease challenge.
Product Information for Veterinary Healthcare Professionals
Nobilis Rismavac consists of a suspension of living cultured avian cells containing at least 3.0 log10 TCID50 of attenuated Marek’s Disease virus (strain CVI 998) per dose. The vaccine is supplied in frozen ampoules held in metal canes stored in a liquid nitrogen canister. Diluent Cell Associated Marek vaccine is supplied for reconstitution of the vaccine prior to use. For uses, dosage, contra-indications and warnings, see datasheet. Further information is available on request.
Ampoules containing 1000, 2000, 4000 or 5000 doses supplied together with Nobilis Diluent CA. Not all presentations may be marketed.
Summary of Product Characteristics
For Summary of Product Characteristics, first click on this link. Then type in Nobilis Rismavac in Product name field. Click on Run search. Subsequently click on View SPC on line listing opposite Nobilis Rismavac.